- Repros Therapeutics (NASDAQ:RPRX -1.3%) Q2 results: Revenues: $2K; Net Loss: ($8.7M) (-20.8%); Loss Per Share: ($0.38) (unch); Quick Assets: $60.7M (-19.9%); Cash Burn: ($14.8M) (-15.6%).
- No financial guidance given.
More on Repros Q2 results
Recommended For You
More Trending News
About RPRX Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| RPRX | - | - |
| Royalty Pharma plc | ||